Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Национальный Институт РакаfiledCriticalНациональный Институт Рака
Priority to UAU201200847UpriorityCriticalpatent/UA71011U/en
Publication of UA71011UpublicationCriticalpatent/UA71011U/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
A method for treating melanoma with metastases in the regional lymph nodes comprises the standard surgical treatment (regional lymphodissection and extensive dissection of the primary tumor) supplemented with high dose α-2b-interferon administered subcutaneously at a dose of 9 million units prior to surgery (Day 1-22 of the treatment course) and 3 million units thrice a week following surgery for 12 months.
UAU201200847U2012-01-272012-01-27Method for treating melanoma with metastases in regional lymph nodes
UA71011U
(en)